SYNGENE
Syngene International Limited
Healthcare Research, Analytics & Technology · ₹16,772 Cr market cap
India's first Contract Research Organization, Syngene provides integrated drug discovery, development, and manufacturing services through a single platform known as CRAMS. Established in 1993 as a Biocon subsidiary, the company operates extensive research and manufacturing facilities spanning multiple locations across the country. It serves global pharmaceutical and biotechnology clients with end-to-end solutions, from early-stage research through commercial-scale production.
4
Tracked investors holding
2
Tracked moves
₹415
Share price
Latest activity
Nippon India Mutual FundIncreased
Nippon India Mutual Fund bought 16,00,307 shares of Syngene International for ₹69.62 Cr at ₹435.05 apiece in an open market transaction, increasing its stake from 6.72% to 7.12%.
Top investors holding Syngene International Limited
Plus 1 more tracked investor holding Syngene International Limited. Sign in to see them all.
Sign in to view all holdersTrack smart money in Syngene International Limited
Get alerted when a top investor buys or sells.
Get started